Azithromycin and early allograft function after lung transplantation: A randomized, controlled trial
- 1 March 2019
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 38 (3) , 252-259
Abstract
No abstract availableKeywords
Funding Information
- KU Leuven
- KU Leuven
This publication has 29 references indexed in Scilit:
- Macrolide Antibiotics and Survival in Patients With Acute Lung InjuryChest, 2012
- Spirometric Obstructive Lung Function Pattern Early After Lung TransplantationTransplantation, 2012
- Clinical and immunological evaluation of 12‐month azithromycin therapy in chronic lung allograft rejectionClinical Transplantation, 2011
- Long-term azithromycin therapy for bronchiolitis obliterans syndrome: Divide and conquer?The Journal of Heart and Lung Transplantation, 2010
- A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantationEuropean Respiratory Journal, 2010
- Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndromeThe Journal of Heart and Lung Transplantation, 2010
- A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapyEuropean Respiratory Journal, 2008
- Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injuryTransplant International, 2008
- Long-Term Azithromycin for Bronchiolitis Obliterans Syndrome After Lung TransplantationTransplantation, 2008
- Long-Term Azithromycin Use for Treatment of Bronchiolitis Obliterans Syndrome in Lung Transplant RecipientsThe Journal of Heart and Lung Transplantation, 2005